GABRIEL KASPER: Open Payments
NPI 1104233808 · DANVERS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$407 in 19 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $407
Food & beverage: $407
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $173 |
| ABBVIE INC. | 2 | $36 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $34 |
| Madrigal Pharmaceuticals | 1 | $27 |
| Acella Pharmaceuticals, LLC | 1 | $24 |
| Sandoz Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $21 |
| TOLMAR, INC. | 1 | $19 |
| Ascendis Pharma Endocrinology Inc | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
Products named: EVENITY, SYNTHROID, ISTURISA, REZDIFFRA, NP Thyroid 60, JUBBONTI, Ozempic, JATENZO.
Industry payments across MA — which companies pay providers there.
